BioCentury | Apr 27, 2009
Clinical News

Ariad preclinical data

...>60-400-fold selectivity over insulin-like growth factor 1 receptor ( IGF1R , CD221 ) and insulin receptor tyrosine kinase (IRTK...
BioCentury | Oct 2, 2008
Distillery Therapeutics

This Week in Therapeutics therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Endocrine disease Diabetes Insulin receptor tyrosine kinase...
BioCentury | Aug 25, 2008
Company News

RecepterBio Inc., Telik deal eligible for undisclosed milestone payments and royalties. ReceptorBio’s lead compound, RB101 , an insulin receptor tyrosine kinase (IRTK...
BioCentury | May 10, 1999
Clinical News

Merck Research Laboratories preclinical data

...researchers published in Science the identification of a small molecule, L-783,281, that selectively activates the insulin receptor tyrosine kinase...
Items per page:
1 - 4 of 4